Cargando…

Clinical evaluations of pituitary apoplexy in incidental nonfunctional pituitary adenomas

Pituitary apoplexy is an uncommon syndrome that often results in spontaneous hemorrhage or infarction of pituitary tumors or glands. We previously reported pituitary apoplexy occurred most frequently in nonfunctional pituitary adenomas among all types of pituitary incidentalomas. In the present stud...

Descripción completa

Detalles Bibliográficos
Autores principales: Takeshita, Kaori, Abe, Ichiro, Kameda, Wataru, Ishii, Kota, Fujita, Yuya, Nagata, Mai, Ochi, Kentaro, Senda, Yuki, Koga, Midori, Kudo, Tadachika, Hada, Yurika, Takase, Kaoru, Morinaga, Yusuke, Ito, Miiko, Abe, Makiko, Ishizawa, Kenichi, Kobayashi, Kunihisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9771219/
https://www.ncbi.nlm.nih.gov/pubmed/36550872
http://dx.doi.org/10.1097/MD.0000000000032026
_version_ 1784854774098690048
author Takeshita, Kaori
Abe, Ichiro
Kameda, Wataru
Ishii, Kota
Fujita, Yuya
Nagata, Mai
Ochi, Kentaro
Senda, Yuki
Koga, Midori
Kudo, Tadachika
Hada, Yurika
Takase, Kaoru
Morinaga, Yusuke
Ito, Miiko
Abe, Makiko
Ishizawa, Kenichi
Kobayashi, Kunihisa
author_facet Takeshita, Kaori
Abe, Ichiro
Kameda, Wataru
Ishii, Kota
Fujita, Yuya
Nagata, Mai
Ochi, Kentaro
Senda, Yuki
Koga, Midori
Kudo, Tadachika
Hada, Yurika
Takase, Kaoru
Morinaga, Yusuke
Ito, Miiko
Abe, Makiko
Ishizawa, Kenichi
Kobayashi, Kunihisa
author_sort Takeshita, Kaori
collection PubMed
description Pituitary apoplexy is an uncommon syndrome that often results in spontaneous hemorrhage or infarction of pituitary tumors or glands. We previously reported pituitary apoplexy occurred most frequently in nonfunctional pituitary adenomas among all types of pituitary incidentalomas. In the present study, we aimed to investigate the characteristics of pituitary apoplexy in patients with incidental nonfunctional pituitary adenomas. 65 patients with pituitary incidentaloma were enrolled. All patients underwent clinical/endocrinological/pathological investigations. As a result, 33 patients were diagnosed with nonfunctional pituitary adenomas. Of these, 12.1% of patients had pituitary apoplexy. There was no difference in tumor diameter, age, or sex between the apoplexy and the non-apoplexy groups. However, the liver enzymes aspartate transaminase and alanine aminotransferase were significantly higher, and plasma sodium and chloride levels were significantly lower in the apoplexy group than in the non-apoplexy group (each P < .05). In addition, low-density lipoprotein-cholesterol was significantly higher in the apoplexy group than in the non-apoplexy group (P < .05). Besides, thyroid-stimulating hormone, luteinizing hormone, follicle-stimulating hormone, and prolactin deficiencies were significantly more frequent in the apoplexy group than in the non-apoplexy group (each P < .05), and growth hormone and adrenocorticotropic hormone deficiencies were more frequent in the apoplexy group than in the non-apoplexy group (P = .09 and.08, respectively). Furthermore, tumor diameter was not associated with pituitary apoplexy, whereas thyroid-stimulating hormone, luteinizing hormone, and follicle-stimulating hormone deficiencies were significantly associated with the apoplexy group (each P < .05). Hence, the present study indicated that pituitary apoplexy could not be related to tumor diameter. Moreover, hormonal deficiencies, hepatic dysfunction, hyponatremia or hypochloremia, and dyslipidemia might be indicators of pituitary apoplexy. There could be the possibility the treatment for dyslipidemia prevents pituitary apoplexy.
format Online
Article
Text
id pubmed-9771219
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-97712192022-12-22 Clinical evaluations of pituitary apoplexy in incidental nonfunctional pituitary adenomas Takeshita, Kaori Abe, Ichiro Kameda, Wataru Ishii, Kota Fujita, Yuya Nagata, Mai Ochi, Kentaro Senda, Yuki Koga, Midori Kudo, Tadachika Hada, Yurika Takase, Kaoru Morinaga, Yusuke Ito, Miiko Abe, Makiko Ishizawa, Kenichi Kobayashi, Kunihisa Medicine (Baltimore) 4300 Pituitary apoplexy is an uncommon syndrome that often results in spontaneous hemorrhage or infarction of pituitary tumors or glands. We previously reported pituitary apoplexy occurred most frequently in nonfunctional pituitary adenomas among all types of pituitary incidentalomas. In the present study, we aimed to investigate the characteristics of pituitary apoplexy in patients with incidental nonfunctional pituitary adenomas. 65 patients with pituitary incidentaloma were enrolled. All patients underwent clinical/endocrinological/pathological investigations. As a result, 33 patients were diagnosed with nonfunctional pituitary adenomas. Of these, 12.1% of patients had pituitary apoplexy. There was no difference in tumor diameter, age, or sex between the apoplexy and the non-apoplexy groups. However, the liver enzymes aspartate transaminase and alanine aminotransferase were significantly higher, and plasma sodium and chloride levels were significantly lower in the apoplexy group than in the non-apoplexy group (each P < .05). In addition, low-density lipoprotein-cholesterol was significantly higher in the apoplexy group than in the non-apoplexy group (P < .05). Besides, thyroid-stimulating hormone, luteinizing hormone, follicle-stimulating hormone, and prolactin deficiencies were significantly more frequent in the apoplexy group than in the non-apoplexy group (each P < .05), and growth hormone and adrenocorticotropic hormone deficiencies were more frequent in the apoplexy group than in the non-apoplexy group (P = .09 and.08, respectively). Furthermore, tumor diameter was not associated with pituitary apoplexy, whereas thyroid-stimulating hormone, luteinizing hormone, and follicle-stimulating hormone deficiencies were significantly associated with the apoplexy group (each P < .05). Hence, the present study indicated that pituitary apoplexy could not be related to tumor diameter. Moreover, hormonal deficiencies, hepatic dysfunction, hyponatremia or hypochloremia, and dyslipidemia might be indicators of pituitary apoplexy. There could be the possibility the treatment for dyslipidemia prevents pituitary apoplexy. Lippincott Williams & Wilkins 2022-12-16 /pmc/articles/PMC9771219/ /pubmed/36550872 http://dx.doi.org/10.1097/MD.0000000000032026 Text en Copyright © 2022 the Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial License 4.0 (CCBY-NC) (https://creativecommons.org/licenses/by-nc/4.0/) , where it is permissible to download, share, remix, transform, and buildup the work provided it is properly cited. The work cannot be used commercially without permission from the journal.
spellingShingle 4300
Takeshita, Kaori
Abe, Ichiro
Kameda, Wataru
Ishii, Kota
Fujita, Yuya
Nagata, Mai
Ochi, Kentaro
Senda, Yuki
Koga, Midori
Kudo, Tadachika
Hada, Yurika
Takase, Kaoru
Morinaga, Yusuke
Ito, Miiko
Abe, Makiko
Ishizawa, Kenichi
Kobayashi, Kunihisa
Clinical evaluations of pituitary apoplexy in incidental nonfunctional pituitary adenomas
title Clinical evaluations of pituitary apoplexy in incidental nonfunctional pituitary adenomas
title_full Clinical evaluations of pituitary apoplexy in incidental nonfunctional pituitary adenomas
title_fullStr Clinical evaluations of pituitary apoplexy in incidental nonfunctional pituitary adenomas
title_full_unstemmed Clinical evaluations of pituitary apoplexy in incidental nonfunctional pituitary adenomas
title_short Clinical evaluations of pituitary apoplexy in incidental nonfunctional pituitary adenomas
title_sort clinical evaluations of pituitary apoplexy in incidental nonfunctional pituitary adenomas
topic 4300
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9771219/
https://www.ncbi.nlm.nih.gov/pubmed/36550872
http://dx.doi.org/10.1097/MD.0000000000032026
work_keys_str_mv AT takeshitakaori clinicalevaluationsofpituitaryapoplexyinincidentalnonfunctionalpituitaryadenomas
AT abeichiro clinicalevaluationsofpituitaryapoplexyinincidentalnonfunctionalpituitaryadenomas
AT kamedawataru clinicalevaluationsofpituitaryapoplexyinincidentalnonfunctionalpituitaryadenomas
AT ishiikota clinicalevaluationsofpituitaryapoplexyinincidentalnonfunctionalpituitaryadenomas
AT fujitayuya clinicalevaluationsofpituitaryapoplexyinincidentalnonfunctionalpituitaryadenomas
AT nagatamai clinicalevaluationsofpituitaryapoplexyinincidentalnonfunctionalpituitaryadenomas
AT ochikentaro clinicalevaluationsofpituitaryapoplexyinincidentalnonfunctionalpituitaryadenomas
AT sendayuki clinicalevaluationsofpituitaryapoplexyinincidentalnonfunctionalpituitaryadenomas
AT kogamidori clinicalevaluationsofpituitaryapoplexyinincidentalnonfunctionalpituitaryadenomas
AT kudotadachika clinicalevaluationsofpituitaryapoplexyinincidentalnonfunctionalpituitaryadenomas
AT hadayurika clinicalevaluationsofpituitaryapoplexyinincidentalnonfunctionalpituitaryadenomas
AT takasekaoru clinicalevaluationsofpituitaryapoplexyinincidentalnonfunctionalpituitaryadenomas
AT morinagayusuke clinicalevaluationsofpituitaryapoplexyinincidentalnonfunctionalpituitaryadenomas
AT itomiiko clinicalevaluationsofpituitaryapoplexyinincidentalnonfunctionalpituitaryadenomas
AT abemakiko clinicalevaluationsofpituitaryapoplexyinincidentalnonfunctionalpituitaryadenomas
AT ishizawakenichi clinicalevaluationsofpituitaryapoplexyinincidentalnonfunctionalpituitaryadenomas
AT kobayashikunihisa clinicalevaluationsofpituitaryapoplexyinincidentalnonfunctionalpituitaryadenomas